Metropolitan Life Insurance Company (MetLife)’s Mirum Pharmaceuticals MIRM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,445	Closed	-$36.3K	–	1277
2024 Q1	$36.3K	Hold	1,445	–	–	﹤0.01%	1563
2023 Q4	$42.7K	Hold	1,445	–	–	﹤0.01%	1534
2023 Q3	$45.7K	Sell	1,445 -19	-1%	-$520	﹤0.01%	1453
2023 Q2	$37.9K	Buy	1,464 +486	+50%	+$12.9K	﹤0.01%	1593
2023 Q1	$23.5K	Hold	978	–	–	﹤0.01%	1798
2022 Q4	$19.1K	Hold	978	–	–	﹤0.01%	2040
2022 Q3	$20.5K	Hold	978	–	–	﹤0.01%	2018
2022 Q2	$19K	Buy	+978	New	+$23.1K	﹤0.01%	2070

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MIRM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Mirum Pharmaceuticals (MIRM) in Q2 2024, closing a stake of 1,445 shares — an estimated $36.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MIRM in Q2 2022 and held it in 8 quarters. The position peaked at $45.7K in Q3 2023. 160 funds tracked by Wall St. Rank hold MIRM as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Mirum Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,445 Mirum Pharmaceuticals shares in Q2 2024, an estimated $36.3K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Mirum Pharmaceuticals in Q2 2022 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s Mirum Pharmaceuticals position peaked at $45.7K in Q3 2023.
160 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.